Contents: Research LetterAdministration of the Coronavirus Disease 2019 (COVID-19) Vaccine to Hospitalized Postpartum PatientsPerez, Marta J. MD; Paul, Rachel MPH; Hirshberg, Jonathan S. MD; Aibangbee, Erica MHS; Ford, Tiana; Cooke, Emily PharmD; Carter, Ebony B. MD, MPH; Odibo, Anthony O. MD, MSCE; Raghuraman, Nandini MD, MS; Kelly, Jeannie C. MD, MS Author Information Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri; Meharry Medical College, Nashville, Tennessee; and the Department of Pharmacy, Barnes-Jewish Hospital, St. Louis, Missouri. Corresponding author: Marta Perez, MD, Department of Obstetrics and Gynecology Washington University School of Medicine, St. Louis, MO; email: [email protected]. Financial Disclosure Marta J. Perez reports receiving funds from Bayer Pharmaceuticals for serving on the Speaker Bureau (2019). The other authors did not report any potential conflicts of interest. Each author has confirmed compliance with the journal's requirements for authorship. Published online ahead-of-print September 9, 2021. Peer reviews and author correspondence are available at https://links.lww.com/AOG/C445. Obstetrics & Gynecology 138(6):p 885-887, December 2021. | DOI: 10.1097/AOG.0000000000004590 Buy Corresponding Article Metrics In Brief Inpatient administration of coronavirus disease 2019 (COVID-19) vaccines during obstetric hospitalization is feasible and an opportunity to increase health equity. Corresponding Article Connect the Dots—December 2021 Price, Corley Rachelle; Rizzuto, Jessica; Smith, Gabriella; Rouse, Dwight J. Obstetrics & Gynecology. 138(6):941-942, December 2021. © 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.